An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• Clinically diagnosed as myasthenia gravis

• Those whose MG symptoms are not controlled by the treatment with prednisone

Exclusion Criteria:

• Those who had undergone thymectomy